A month-old request from a Michigan hospital for emergency use authorization to treat COVID-19 patients with hydroxychloroquine has been denied by the U.S. Food and Drug Administration.
The Detroit-area Henry Ford Health System requested to use the anti-malaria drug on a group of patients “meeting very specific criteria” on July 6, MLive reported.
The FDA denied the hospital’s request this week, Dr. Adnan Munkarah, the system’s executive vice president and chief clinical officer, confirmed in a Thursday statement.
